Progressiveazotemia provoked by ACE inhibitor in renal ischemia


如何引用文章

全文:

作者简介

V Fomin

ММА им. И. М. Сеченова

ММА им. И. М. Сеченова

О Taronishvili

ММА им. И. М. Сеченова

ММА им. И. М. Сеченова

M Shvetsov

ММА им. И. М. Сеченова

ММА им. И. М. Сеченова

E Shilov

ММА им. И. М. Сеченова

ММА им. И. М. Сеченова

S Moiseev

ММА им. И. М. Сеченова

ММА им. И. М. Сеченова

V Kushnir

ММА им. И. М. Сеченова

ММА им. И. М. Сеченова

Yu Sorokin

ММА им. И. М. Сеченова

ММА им. И. М. Сеченова

参考

  1. Хирманов В. Н. Ишемическая болезнь почек. Тер. арх. 2001; 6: 61-61.
  2. Alcasar J. M., Rodicio J. L. Ischemic nephropathy: clinical characteristics and treatment. Am. J. Kidney Dis. 2000; 36: 883-893.
  3. Textor S. C, Wilcox С S. Ischemic nephropathy/azotemic renovascular disease. Semin. Nephrol. 2000; 20: 489-502.
  4. Мухин Н. А., Козловская Л. В., Кутырина И. М. и др. Ишемическая болезнь почек. Тер. арх. 2003; 6: 6-12.
  5. Grossman A., Eckland D., Price P., Edwards C. R. Captopril: reversible renal failure with severe hyperkalemia. Lancet 1980; 1: 712.
  6. Hricik D. E., Browning P. J., Kopelman R. et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kid-ney. N. Engl. J. Med. 1983; 308: 373-376.
  7. Coulie P., De Plaen J. F., van Ypersele de Strihou С Captopril induced acute reversible renal failure. Nephron 1983; 35: 108- 111.
  8. Dominiczak A., Isles C, Gillen G., Brown J. J. Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease. J. Hum. Hypertens. 1988; 2: 53-56.
  9. O'Donnell D. Renal failure due to enalapril and captopril in bilateral renal artery stenosis: greater awareness needed. Med. J. Aust. 1988; 148: 525-527.
  10. Hannedouche Т., Godin M., Fries D., Fillastre J. P. Acute renal thrombosis induced by angiotensin-converting enzyme inhibitors in patients with renovascular hypertension. Nephron 1991; 57: 230-231.
  11. Svarstad E., Willassen Y., Iversen В. М. Severe renal failure during treatment with angiotensin-converting enzyme inhibi tors. Tidsskr. Norske Laegeforen. 1992; 112: 463-465.
  12. Lakusic N., Mahovic D., Ciglenecki N. et al. Reversible impair ment of renal function during treatment with lisinopril, and ACE-inhibitor (case report). Lijec. Vjesn. 2001; 123: 245-248.
  13. Svarstad E., Hultstrom D., Jensen D. et al. Acute renal failure, renal artery stenosis and angiotensin-converting enzyme (ACE) inhibitor. Tidsskr. Norske Laegeforen. 2001; 121: 1784-1788.
  14. Silas J. H., Klenka Z., Solomon S. A., Bone J. M. Captopril induced reversible renal failure: a marker of renal artery stenosis affecting a solitary kidney. Br. Med. J. (Clin. Res. Ed.) 1983; 286: 1702-1703.
  15. Chabrier G., Simon С, Cherfan J. et al. Acute renal insufficiency induced by captopril disclosing renal artery stenosis in a solitary kidney. Rev. Med. Interne 1985; 6: 58-61.
  16. Lynggaard F., Jespersen С. M. Reversible renal failure due to captopril in a patient with renal artery stenosis in a solitary functioning kidney. Ugeskr. Laeg. 1985; 147: 1549-1550.
  17. Scanu P., Hurault de Ligny В., Ryckelynck J. P. Reversible acute renal insufficiency with combination of enalapril and diuretics in a patient with a single renal-artery stenosis. Nephron 1987; 45: 321-322.
  18. Mason J. C, Hilton P. J. Reversible renal failure due to captopril in a patient with transplant artery stenosis. Case report. Hypertension 1983; 5: 623-627.
  19. van Son W. J., van der Woude F. J., Tegzess A. M. Captoprilinduced deterioration of graft function in patients with a transplant renal artery stenosis. Proc. Eur. Dial. Transplant. Assoc. 1983; 20: 325-330.
  20. Tripathi K., Srivastava P. K., Tewari N. N, Mishra P. S. Reversible renal failure in autotransplanted restenosed bilateral renal artery stenosis with captopril. J. Assoc. Physicians India 1985; 33: 617.
  21. van de Ven P. J., Beutler J. J., Kaatee R. et al. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int. 1998; 53: 986-993.
  22. Wynckel A., Ebikili В., Melin J. P. et al. Long-term followup of acute renal failure caused by angiotensin converting enzyme inhibitors. Am. J. Hypertens. 1998; 11: 1080-1086.
  23. Devoy M. A., Tomson С R., Edmunds M. E. et al. Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J. Intern. Med. 1992; 232: 493-498.
  24. Adhiyaman V., Asghar M., Оке A. et al. Nephrotoxicity in the elderly due to coprescription of angiotensin-converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs. J. Roy. Soc. Med. 2001; 94: 512-514.
  25. Baraldi A., Ballestri M., Rapana R. et al. Acute renal failure of medical type in an elderly population. Nephrol. Dial. Transplant. 1998; 13 (suppl. 7): 25-29.
  26. Stirling C, Houston J., Robertson S. et al. Diarrhoea, vomiting and ACE inhibitors: an important cause of acute renal failure.J. Hum. Hypertens. 2003; 17: 419-423.
  27. Schepkens H., Vanholder R., Billiouw J. M., Lameire N. Lifethreatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. Am. J. Med. 2001; 110: 438-441.
  28. Pedersen E. B. New tools in diagnosing renal artery stenosi Kidney Int. 2000; 57: 2657-2677.
  29. Alcasar J. M., Marin R., Gomez- Campdera F. et al. Clinic. characteristics of ischaemic renal disease. Nephrol. Dia Transplant. 2001; 16 (suppl. 1): 74-77.
  30. Staessen J. A., Gasowski J., Wang J. L. et al. Risks of untreate and treated isolated systolic hypertension in the elderly: meia analysis of outcome trials. Lancet 2000; 355: 865-872.
  31. Кобалава Ж. Д., Моисеев В. С. Систолическое давление ключевой показатель диагностики, контроля и прогнози рования риска артериальной гипертонии. Возможност блокады рецепторов ангиотензина II. Клин, фармакол.тер. 2000; 9: 86-95.
  32. Cirillo M., Stellate D., Laurenzi M. et al. Pulse pressure an isolated systolic hypertension: association with microalbuminu ria. The GUBBIO Study Collaborative Research Group. Kid ney Int. 2000; 58: 1211-1218.
  33. Ming J., Sheng L. L., Zhang L. G. et al. Abnormal renal func tion in isolated systolic hypertension correlation with ambula tory blood pressure. Int. J. Cardiol. 1993; 41: 69-75.
  34. Voyaki S. M., Staessen J. A., Thijs L. et al. Follow-up of rena function in treated and untreated older patients with isolatei systolic hypertension. Systolic Hypertension in Europe (Syst Eur) Trial Investigators. J. Hypertens. 2001; 19: 511-519.
  35. SHEP Cooperative Research Group. Prevention of stroke b; antihypertensive drug treatment in older persons with isolate< systolic hypertension. J. A. M. A. 1991; 265: 3255-3264.
  36. Forette F., Seux M. L., Staessen J. A. Prevention of dementi: in randomized doubleblind placebo-controlled systolic hyper tension in Europe (SYST-EUR) trial. Lancet 1998; 352 1347-1351.
  37. Brown M. J., Palmer С R., Castaigne A. et al. Influence of diabetes and type of hypertension on response to antihypertensivi treatment. Hypertension 2000; 35: 1038-1042.
  38. Zanchetti A., Bold G., Hennig M. et al. Calcium antagonist lac idipin slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European Lacidipine Stud) on Atherosclerosis (ELSA), a randomized, double-blind, longterm trial. Circulation 2002; 106: 2422-2427.
  39. van Zweiten P. A. Drug treatment of isolated systolic hypertension. Nephrol. Dial. Transplant. 2001; 16: 1095-1097.
  40. Blanco-Colio L. M., Tunon J., Martin-Ventura J. L., Egido J Antiinflammatory and immunomodulatory effects of statins Kidney Int. 2003; 63: 12-23.

版权所有 © Consilium Medicum, 2004

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 
 


##common.cookie##